GI Grand Rounds – Topics (2007-2008)
Acute esophageal necrosis
Acute interstitial nephritis
Alternative medicines for IBS
Anal stenosis in an elderly patient with constipation
Antidepressants and GI side effects
Anti-TNF rx in IBD: risk of cancer
Appendicitis
Bacteria in PSC
Balloon dilation of strictures in Crohn’s disease
Barrett’s esophagus and chemoprevention
Barrett’s surveillance versus ablation
Biliary stent (covered) in bile leaks
Bioethics in medicine
Biologics in perioperative Crohn’s management
Breath test for bacterial overgrowth
C. difficile colitis in health care workers
Cholestasis
Colorectal lymphoma
Combination drug therapy for chronic HBV
Crohn’s disease and vulvar lesions
De Novo IBD s/p liver transplant
Depression in Crohn’s disease
Diarrhea in RMSF (20%)
Disorders of defecation
Distal intestinal obstruction syndrome
Diverticular colitis
Effects of IBD drugs on HCV
ERCP in Ehlers-Danlos
ERCP in gallstone pancreatitis
Esophageal reflux tests
Esophageal stents
Esophageal ulcer
Esophageal ulcers (large) ? Idiopathic HIV ulceration
EUS-guided celiac pleuralysis in pancreatic cancer and chronic pancreatitis
EUS-guided ERCP and biliary-pancreatic drainage
Explosive patients – H2, CH4
Extraintestinal manifestation of IBD: pericarditis + 3-fold risk
Fish oil in IBD
Flat adenomas
Flat/depressed colon lesions
GAVE vs portal hypertensive gastropathy
Genetic predispositions to pancreatitis
GERD and pregnancy
Hemachromatosis in black male without known mutation
Hemangioma (large) of the liver
Hepatitis B and TNF inhibitors
Hepatitis delta
Hiccups
High-grade dysplasia in 1 cm tumor resected > metastatic cancer in one year
High ostomy output response to budesonide
Hirschsprung’s disease
Hyperplastic polyposis and serrated adenomas
Hyponatremia and liver organ allocation: effect on MELD
IBD therapy
Imaging for rectal cancer
Indeterminant colitis
Infliximab therapy
Intestinal amyloidosis
Intestinal neuronal dysplasia
Kayexalate colitis
Large cecal adenoma over ileocecal valve
Medical therapy for fistulizing Crohn’s disease
Mesenteric hematoma
Methotrexate in Crohn’s
Mid-level providers in GI
NAFLD – is biopsy worthwhile?
Natalizumab
New onset “heartburn” actually angina
Nutrition infusion reactions: immunology and management
Operative risk in liver disease
Oral contraceptives and Crohn’s disease
Oral methotrexate in Crohn’s
Ovarian cancer
Pancreatic cystic lesions
Pancreatic mass (hypervascular) masquerading as tumor
Pancreatic pseudocyst
Pancreatitis
Paraneoplastic syndromes and GI dysmotility
PEG for palliative decompression and carcinomatosis
PEG/interferon-induced neutropenia
Photodynamic therapy
Pneumatosis intestinalis
Polyposis (prolapse effect)
Post-colonoscopy diarrhea
Post-ERCP and poor prognosis (vanishing ducts)
Post-Nissen dysphagia
Post-OLT pulmonary opacities (Ca++)
Pregnancy in autoimmune hepatitis
Psychopharmacology of functional bowel disease
Pyoderma and infliximab
Recurrence of Crohn’s s/p resection – role of bacteria – probiotics have equivocal effects
Renal failure and cryoglobulinemia
Rendez-vous’ procedure for esophageal stricture
Retained capsules in Crohn’s disease
Risk of cancer in ileoanal pouch: none in pouch, but found in retained rectal mucous
Schatzki’s ring and impaction
Screening and surveillance of HCC
Screening for anal cancer
Semi-acute abdix lupus – pseudoobstruction
Skin lesions (calciphylaxis) in IBD (deep necrotic)
Solitary rectal ulcer and colitis cystica profunda
SSRI’s and GI bleeding
Stem cell transplant in Crohn’s disease
Stricture management for eosinopilic esophagitis: self-expanding stent (not very successful) vs steroid injection
Sugar intolerance
Use of CT scan in the diagnosis of NAFLD
Value of alarm symptoms in the diagnosis of IBS
Vanishing duct syndrome – post OLT cholestasis